Aktiver Ansatz zahlt sich aus - aus der «Finanz und Wirtschaft» Nr. 16
27 February 2021
Download
NovellusDx Establishes Fore Biotherapeutics and Appoints Dieter Weinand as Chairman of the Board and Usama Malik as Chief Executive Officer and Director of the Board
22 February 2021
Download
Swixx BioPharma SA of Baar, Switzerland announced today that it had signed eighteen deals for new territories and / or products over the past year
5 February 2021
Download
Horizon Therapeutics to acquire HBM portfolio company Viela Bio for USD 3.05 billion in cash
1 February 2021
Download
Arcutis Announces Positive Topline Results from Pivotal DERMIS-1 and -2 Phase 3 Trials of Topical Roflumilast Cream (ARQ-151) in Plaque Psoriasis
1 February 2021
Download
Narrow River Management Announces Formation and Financing of Two New Companies Developing Therapies for Renal Diseases
27 January 2021
Download
Farmalatam Holding Inc. (Farmalisto) achieves investment of US $ 18 million from the IDB Invest, HBM Healthcare Investments Ltd. and Morgan Río Capital Management
15 January 2021
Download
IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncologypdf.
13 January 2021
Download
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
11 January 2021
Download
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
9 January 2021
Download
Adrenomed Supervisory Board appoints Dr. Wolfgang Baiker as CEO
4 January 2021
Download
Y-MABS Therapeutics and Swixx Complete CEE & RUSSIA Deal on DANYELZA® and OMBURTAMAB
18 December 2020
Download
BioAtla Announces Pricing of Initial Public Offering
15 December 2020
Download
Nuance Pharma Closes Series D Financing
8 December 2020
Download
Seer Announces Pricing of Initial Public Offering
4 December 2020
Download
Adrenomed Closes EUR 22 Million Equity Financing to Accelerate Development of Adrecizumab (HAM8101) and Provides Business Update
30 November 2020
Download
FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma
25 November 2020
Download
Arcutis Announces Positive Topline Data from Phase 2b Study of ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Scalp and Body Psoriasis
23 November 2020
Download
Enhancing Market Position in the Synthetic Biology Industry to Promote High End Biologically Manufactured Alternatives?A Dialogue with Cathay Biotech Inc. Chairman Liu Xiucai
20 November 2020
Download
ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Promising Initial Clinical Responses in Patients with Advanced Solid Tumors
16 November 2020
Download
Das Derby der Impfstoffhersteller
16 November 2020
Download
Ambrx Closes $200 million in Crossover Financing with Leading Healthcare Investors to Advance its Clinical and Preclinical Pipeline of Precision Biologics
9 November 2020
Download
Gewinne aus dem Labor
1 November 2020
Download
Galecto Announces Pricing of Initial Public Offering
29 October 2020
Download
Arena Pharmaceuticals Announces Launch of Longboard Pharmaceuticals With $56M Financing, Building a Novel Neuroscience Drug Development Company
28 October 2020
Download